What move does the options market price into Emergent BioSolutions's report?

Implied ±29.9%, either direction · provisional.

How often does Emergent BioSolutions move more than the options market prices?

5 of the last 8 reports moved at least as far as the implied move.

EBSNYSEPharmaceutical Preparations

Emergent BioSolutions Inc. (EBS) earnings date, market-implied expected move, and options open interest by expiry

6.00

+0.10 · +1.65%

Regular session11:34 ET

Open5.85Volume2.3MMkt cap$303.3MEPS-5.01

Day5.85 – 6.00100%52-wk4.36 – 14.0617%

EBS

Emergent BioSolutions Inc.

OpenVolumeMkt capP/EEPSDiv yield

Day – 52-wk –

Expected move

Inputs

±29.9%implied · straddle

4.147.66

spot 5.90exp Mar 19ATM strike 6ATM straddle 2.07IV 73%

Nov 4 closeprovisional

Expected move

Inputs

Next report

Feb 25

after close · in 112 days

est.Q4 FY26

Calendar

Next report

Last report

−2.95%

vs ±19.1% implied · ×0.15

shaded = implied · ▲▼ = realized

Nov 2 '26 · confirmed

Implied vs realized

Linked news

3hSABS · customerSAB Biotherapeutics reports net loss of $63,660 thousand for nine months ended September 30, 2026
1dMGNX · supplierMacrogenics appoints Emil Kuriakose and Michael Vasconcelles to board

News

Largest filed tie

13F top-10 QoQ

+7.60%

shares held · 10 largest managers

13F · Jun 30 '26128d lag

195 managers

Top fund weight

1.19%

EBS weight · BINV

N-PORTJun 30 '26

5 funds

Last reportshaded = implied▲▼ = realized× = |realized| ÷ implied

Emergent BioSolutions (EBS) is expected to report on Feb 25 after close (estimated date).

Implied vs realized

8 reports

5 of 8≥ implied

avg implied: ±17.6%
avg realized: ±22.0%

Mar 3 '25Mar 3 '25confirmed±20.3%▼−6.44%×0.32

May 7 '25May 7 '25confirmed±9.8%▲+34.18%×3.48

Aug 6 '25Aug 6 '25confirmed±13.3%▲+36.65%×2.75

Oct 29 '25Oct 29 '25confirmed±23.1%▲+36.60%×1.58

Feb 26 '26Feb 26 '26confirmed±23.5%▼−26.58%×1.13

Q1 FY26Apr 30 '26confirmed±17.3%▲+2.92%×0.17

Q2 FY26Aug 5 '26confirmed±14.3%▼−29.58%×2.07

Q3 FY26Nov 2 '26confirmed±19.1%▼−2.95%×0.15

quarterimplied−40%0+40%realized×

Q3 FY26±19.1%▼−2.95%×0.15

Q2 FY26±14.3%

Shaded = implied · tick ▲▼ = realized · × = |realized| ÷ impliedSource: options EOD · implied at prior close · realized close to close

Implied vs realized

Positioning

OI · 4 expiries · Nov 4 close

0.33OI · 4 expiries · Nov 4 closeP/C open interest · Mar 19 · first expiry after the report

PUTS · chgexpiry · days · P/CCALLS · chgP/C

223+3%Nov 2015d0.161,379−1%0.16

530+1%Dec 1843d0.252,1430%0.25

1,058+1%Jan 1571d0.147,502+1%0.14

report · Feb 25 · after close · est.

220+4%Mar 19134d672+1%

ExpiryPutsCallsP/C

Nov 2015d223+3%1,379−1%0.16

Dec 1843d530+1%2,1430%0.25

Jan 1571d1,058+1%7,502+1%0.14

report · Feb 25 · after close · est.

Hatched = puts · solid = calls · bars scaled per expiry · chg = OI vs prior sessionSource: options EOD

Positioning

Linked exposure

scenario · straddle±29.9%

Funds 4

BINV±0.4%

XBI±0.0%

IWM±0.0%

UWM±0.0%

Dashed = straddleMethod 1 more fund Source: SEC filings · N-PORT · market data

Linked exposure

Revenue flow

as filedQ3 FY26

−29.73%as filednet margin · revenue −53.05% QoQ · −52.40% YoY

Revenue$110M−53.05%

Gross profit$29M26.55%−78.72%

Operating income−$37M−33.91%+70.18%

Pre-tax income−$36M+78.11%

Net income−$33M−29.73%+81.85%

Cost of revenue$81M−16.79%

Operating expenses$67M−74.65%

Tax−$4M−126.62%

Other income$900,000+102.18%

Source: SEC filings · standardized · QE Sep 30 '26 · bars = % of revenue

Revenue flow

Intraday

15m bars

Long dash = implied range · Nov 4 close · Hatch = extended hours · ▯ up · ▮ downSource: market data · 11:30 ET

Intraday

Event sensitivity

PPI ×1.27· ±5.4% vs ±4.3% · 10 releases

eventrelease day|move|up · n×base

PPIproducer prices±5.4%5 of 10×1.27

FOMCrate decision±4.0%11 of 24×0.93

CPIconsumer prices±3.4%4 of 10×0.81

CPROFcorporate profits±3.4%6 of 12×0.79

GDPgross domestic product±3.1%7 of 19×0.74

PCEpersonal income & outlays±3.1%7 of 19×0.73

NFPjobs report±2.4%1 of 10×0.57

Bar = avg |move| to ±6% · tick = ±4.3% avg day · ×base = |move| ÷ ±4.3% · min 6 releases

Earnings history

EPS -0.64 · consensus —

Quarter	Reported	EPS	Consensus
Q3 FY26	Nov 2 '26 · confirmed	-0.64	—
Q2 FY26	Aug 5 '26 · confirmed	-3.49	—
Q1 FY26	Apr 30 '26 · confirmed	0.07	—

Source: filed financials

Methodology

ties · implied moves · holdersMethod